Improved survival of type 2 diabetic patients on renal replacement therapy in Finland

被引:8
作者
Kervinen, Marjo [1 ]
Lehto, Seppo [1 ]
Ikaheimo, Risto [2 ]
Karhapaa, Pauli [1 ]
Gronhagen-Riska, Carola [3 ,4 ]
Finne, Patrik [3 ,5 ]
机构
[1] Kuopio Univ Hosp, Dept Internal Med, SF-70210 Kuopio, Finland
[2] Oulu Univ Hosp, Dept Internal Med, Oulu, Finland
[3] Finnish Registry Kidney Dis, Helsinki, Finland
[4] Univ Helsinki, Cent Hosp, Div Nephrol, Dept Med, Helsinki, Finland
[5] Univ Tampere, Sch Publ Hlth, FIN-33101 Tampere, Finland
关键词
diabetes mellitus; end-stage renal disease; survival; CHRONIC KIDNEY-DISEASE; DIALYSIS PATIENTS; GLYCEMIC CONTROL; CARDIAC-DISEASE; RISK; MANAGEMENT; MORTALITY; FAILURE;
D O I
10.1093/ndt/gfp555
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Methods. Patients who entered RRT because of type 2 diabetes mellitus in 1995-99 (n = 314) and 2000-05 (n = 583) were identified within the Finnish Registry for Kidney Diseases. The two cohorts were followed up from start of RRT until death or end of follow-up on 31 December 2006. Survival probabilities and probabilities of receiving a kidney transplant were calculated using Kaplan-Meier curves. Multivariate modelling was performed using Cox regression. Results. Patients who entered RRT in 2000-05 had lower risk of dying than those who entered in 1995-99; hazard ratio (HR) was 0.76 (95% CI 0.65-0.89) and 0.74 (95% CI 0.63-0.87) with adjustment for age and gender. The decreased risk of death was most obvious in age groups 55-64 (HR 0.67, 95% CI 0.49-0.92) and 65-74 years (HR 0.69, 95% CI 0.56-0.87). Adjustment for albumin in addition to age and gender only slightly weakened the effect of study periods (HR 0.83, 95% CI 0.69-1.01). The patients in 2000-05 were more obese, had lower total and LDL cholesterol and higher HDL cholesterol and albumin concentration in serum than patients in 1995-99. Patients' probability to receive a kidney transplant was low in both groups. Conclusions. Survival of type 2 diabetes patients on RRT improved during the time period 1995-2005 in Finland while the probability of receiving a kidney transplant remained low and unchanged.
引用
收藏
页码:892 / 896
页数:5
相关论文
共 50 条
  • [1] Effect of Vascular Comorbidities on Survival of Type 2 Diabetes Patients on Renal Replacement Therapy
    Kervinen, Marjo
    Lehto, Seppo
    Gronhagen-Riska, Carola
    Finne, Patrik
    AMERICAN JOURNAL OF NEPHROLOGY, 2012, 36 (06) : 509 - 515
  • [2] Comorbidities and survival of patients with type 1 diabetes on renal replacement therapy
    J. Helve
    M. Haapio
    P.-H. Groop
    C. Grönhagen-Riska
    P. Finne
    Diabetologia, 2011, 54 : 1663 - 1669
  • [3] Comorbidities and survival of patients with type 1 diabetes on renal replacement therapy
    Helve, J.
    Haapio, M.
    Groop, P. -H.
    Gronhagen-Riska, C.
    Finne, P.
    DIABETOLOGIA, 2011, 54 (07) : 1663 - 1669
  • [4] Type 2 diabetic patients on renal replacement therapy: Probability to receive renal transplantation and survival after transplantation
    Kervinen, Marjo H.
    Lehto, Seppo
    Helve, Jaakko
    Gronhagen-Riska, Carole
    Finne, Patrik
    PLOS ONE, 2018, 13 (08):
  • [5] Biochemical Variables and Survival of Patients with Type 1 Diabetes on Renal Replacement Therapy
    Helve, Jaakko
    Haapio, Mikko
    Groop, Per-Henrik
    Gronhagen-Riska, Carola
    Finne, Patrik
    BLOOD PURIFICATION, 2014, 38 (01) : 18 - 23
  • [6] Early initiation of renal replacement therapy improves survival in patients with acute kidney injury
    Knezevic, Violeta
    Azasevac, Tijana
    Simin, Marija Sibalic
    Sladojevic, Vesna
    Urosevic, Ivana
    Celic, Dejan
    VOJNOSANITETSKI PREGLED, 2021, 78 (10) : 1028 - 1035
  • [7] Association between markers of glycemic control, cardiovascular complications and survival in type 2 diabetic patients with end-stage renal disease
    Okada, Tomonari
    Nakao, Toshiyuki
    Matsumoto, Hiroshi
    Shino, Tamami
    Nagaoka, Yume
    Tomaru, Ryo
    Wada, Toshikazu
    INTERNAL MEDICINE, 2007, 46 (12) : 807 - 814
  • [8] Improved Survival and Renal Prognosis of Patients With Type 2 Diabetes and Nephropathy With Improved Control of Risk Factors
    Andresdottir, Gudbjorg
    Jensen, Majken L.
    Carstensen, Bendix
    Parving, Hans-Henrik
    Rossing, Kasper
    Hansen, Tine W.
    Rossing, Peter
    DIABETES CARE, 2014, 37 (06) : 1660 - 1667
  • [9] Survival of South African patients on renal replacement therapy
    Jardine, Thabiet
    Wong, Esther
    Steenkamp, Retha
    Caskey, Fergus J.
    Davids, Mogamat Razeen
    CLINICAL KIDNEY JOURNAL, 2020, 13 (05) : 782 - 790
  • [10] The Role of Vildagliptin in the Therapy of Type 2 Diabetic Patients with Renal Dysfunction
    Trevisan, Roberto
    DIABETES THERAPY, 2017, 8 (06) : 1215 - 1226